Form D · Other Health Care
Singularity Sciences Inc
Boston, MA · CIK 0001770966
Offering snapshot reported Jul 23, 2019 · SEC filing
- Reported sold
- $53K Offering amount: $150K
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Mar 18, 2019 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$48,000 → $53,000
- Reported investors5 → 6
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 23, 2019 | Amendment | $53,000 | $5,000vs Apr 1, 2019 | 6 | SEC filing |
| Apr 1, 2019 | Initial | $48,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 04
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-336129
Source: Form D, filed Jul 23, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Spencer Lichtenstein | Director, Executive |
| Issac Lichtenstein | Director, Executive |
| Isaac Lichtenstein | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
177 Huntington Ave Suite 179072
Boston, MA, 02115
Boston, MA, 02115